FDA launches pilot program that aims to speed the time to first-in-human drug trials
at seekingalpha.com (Tue, 15-Sep 11:26 AM)
Regeneron and Sanofi Complete Key Dupilumab Itch Study, Expanding Dermatology Upside
at www.tipranks.com (Fri, 11-Sep 12:30 PM)
Dupixent’s Next Move: STYLE 1 Itch Study Wraps Up for Regeneron and Sanofi
at www.tipranks.com (Fri, 11-Sep 12:30 PM)
at www.tipranks.com (Thu, 10-Sep 8:30 AM)
Dupixent, EYLEA HD, and Libtayo Drive Regeneron's Double-Digit Revenue and EPS Growth in Q2 2026
Market Chameleon (Thu, 30-Jul 7:37 AM)
Cemdisiran Regulatory Reviews Put Regeneron at the Forefront of Rare Disease Innovation
Market Chameleon (Mon, 22-Jun 8:59 AM)
